Literature DB >> 28704640

The pitfalls of biomarker-based classification schemes.

Ignacio Illán-Gala1, Eduard Vilaplana1, Jordi Pegueroles1, Victor Montal1, Daniel Alcolea1, Rafael Blesa1, Alberto Lleó1, Juan Fortea2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28704640     DOI： 10.1016/j.jalz.2017.06.002

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN： 1552-5260            Impact factor:   21.566


× No keyword cloud information.
  3 in total

Review 1.  Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.

Authors:  Dallas P Veitch; Michael W Weiner; Paul S Aisen; Laurel A Beckett; Charles DeCarli; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Susan M Landau; John C Morris; Ozioma Okonkwo; Richard J Perrin; Ronald C Petersen; Monica Rivera-Mindt; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; Duygu Tosun; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2021-09-28       Impact factor: 16.655

2.  Letter.

Authors:  Ara S Khachaturian
Journal:  Alzheimers Dement (Amst)       Date:  2017-11-21

3.  Challenges associated with biomarker-based classification systems for Alzheimer's disease.

Authors:  Ignacio Illán-Gala; Jordi Pegueroles; Victor Montal; Eduard Vilaplana; María Carmona-Iragui; Daniel Alcolea; Bradford C Dickerson; Raquel Sánchez-Valle; Mony J de Leon; Rafael Blesa; Alberto Lleó; Juan Fortea
Journal:  Alzheimers Dement (Amst)       Date:  2018-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.